Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Global plant based biomanufacturing market will report an impressive CAGR in the forecast period, 2022-2026. The market growth can be attributed to the advancing healthcare capabilities to device treatment from plant based elements. Moreover, increasing number of pipeline products that are a part of plant based biologics is further drive the growth of the global plant based biomanufacturing market in the upcoming five years. Also, rising demands for the human biologics, and to make these procedures affordable and less time consuming, the global plant based biomanufacturing market is expected to grow substantially in the next five years. Additionally, recent developments in plant expression vectors, downstream processing, and glycoengineering have established plants as a superior alternative to biologics production. As a next best commercial development in the field of biotechnology the global plant based biomanufacturing market is anticipated to register esteemed growth in the future five years.
Plant based biomanufacturing includes protein manufacturing processes through recombinant protein production. These proteins include protein biopolymers, industrial proteins and enzymes, and therapeutic proteins. The production processes involve a narrowing diversity of bioreactors for cell, hairy root, microalgae, and moss cultivation. Direct use of cultivated plant cells, whole or minimally processed plants, or plant parts (e.g., seeds, dried leaves) is in development for industrial/bioenergy applications as well as for therapeutics and vaccines and play a vital role in bio-pharmaceutical productions.
The global plant based biomanufacturing is segmented by product type, technology, source, end user, competitional landscape, and regional distribution. Based on product type, the market is further bifurcated into antibodies, vaccines, proteins, biologics, enzyme, and others. Biologics are anticipated to hold the largest revenue shares of the market and dominate the segment in the next five years on the account of changing consumer preferences to more nutritional and herbal products. Consistent research and advancing plant based medicinal nutrient is also driving the growth of the global plant based biomanufacturing market in the upcoming five years. Vaccines are expected to show fastest growing CAGR in the next five years on the account of rapidly evolving drug development procedures that have plant based recombinant proteins. Also, the recent pandemic situation due to COVID-19 has enhanced the healthcare industry inclination toward finding plant based vaccines for the protection against deadly viruses. These factors are actively influencing the growth of the global plant based biomanufacturing market in the future five years of forecast until 2026.
Holding the major shares of the global plant based biomanufacturing market are Pfizer, Inc., Aimmune Therapeutics Inc. (Nestle), Medicago, Inc., Kentucky BioProcessing, Inc., iBio, Inc., PlantForm Corporation, Ventria Bioscience Inc., Protalix Biotherapeutics, Inc., Planet Biotechnology Inc., Zea Biosciences Corp., among others. Market players are actively involved in the research and technological development in the product developments. The advanced technology has made it possible for the industry to provide excellent services through plant based biomanufacturing. Further advancement would aid the market value and brand establishment in the future five years. New market players may focus on the research and development to provide options that satisfies the consumer demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers & acquisitions and new product developments.
Years considered for this report:
- Historical Years: 2016 - 2019
- Base Year: 2020
- Estimated Year: 2021
- Forecast Period: 2022 - 2026
Objective of the Study:
- To analyze the historical growth of the market size of global plant based biomanufacturing market from 2016 to 2019.
- To estimate and forecast the market size of global plant based biomanufacturing market from 2020 to 2026 and growth rate until 2026.
- To classify and forecast global plant based biomanufacturing market based on product type, technology, source, end user, competitional landscape, and regional distribution.
- To identify dominant region or segment in the global plant based biomanufacturing market.
- To identify drivers and challenges for global plant based biomanufacturing market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global plant based biomanufacturing market.
- To identify and analyze the profile of leading players operating in global plant based biomanufacturing market.
- To identify key sustainable strategies adopted by market players in global plant based biomanufacturing market.
The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of manufacturers, suppliers, and distributors across the country. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the manufactures which could not be identified due to the limitations of secondary research. The publisher analyzed the manufactures, distribution channels and presence of all major players across the country.
The publisher calculated the market size of global plant based biomanufacturing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.
Key Target Audience:
- Manufacturers, end users, and other stakeholders
- Distributors and suppliers of products and other stakeholders
- Organizations, forums, and alliances related to plant based biomanufacturing
- Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
Report Scope:
In this report, global plant based biomanufacturing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Global Plant Based Biomanufacturing Market, By Product Type:
- Antibodies
- Vaccines
- Proteins
- Biologics
- Enzyme
- Others
Global Plant Based Biomanufacturing Market, By Technology:
- Upstream
- Downstream
Global Plant Based Biomanufacturing Market, By Source:
- Whole Plant
- Plant Cells
- Seed
- Leaf
- Others
Global Plant Based Biomanufacturing Market, By End User:
- Biotechnology & Pharmaceutical Companies
- Contract Manufacturing Organizations
- Others
Global Plant Based Biomanufacturing Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- South America
- Brazil
- Argentina
- Colombia
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global plant based biomanufacturing market.
Available Customizations:
With the given market data, the publisher offers customizations according to a company’s specific needs.
Table of Contents
Companies Mentioned
- Pfizer, Inc.
- Aimmune Therapeutics Inc. (Nestle)
- Medicago, Inc.
- Kentucky BioProcessing, Inc.
- iBio, Inc.
- PlantForm Corporation
- Ventria Bioscience Inc.
- Protalix Biotherapeutics, Inc.
- Planet Biotechnology Inc.
- Zea Biosciences Corp.
